Compare · 2 funds side by side · dividends reinvested

CURE and SOXL

CUREDirexion×SOXLDirexion×

Versus in desk

Story of the two · Growth5Y$10,000 five years agoDividends reinvested · both on one scale$16,282CURE · best of the two

02 / 04

CURE and SOXL, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

Direxion Daily Healthcare Bull 3X ETFLeveraged · 3x0.94%0.70%+63.4%+99.0%+34.3%+10.2%−31.1%48.7%$200M1.3

Direxion Daily Semiconductor Bull 3X ETFLeveraged · 3x0.91%0.14%+58.8%+37.3%+67.1%+9.3%−77.8%143.0%$18.0B1.8

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 4, 2026 · returns include dividends · since: CURE 2011 · SOXL 2010

Head to Head

Swap sides Versus in desk

Head to Head

Direxion Daily Healthcare Bull 3X ETF · $200M$16,282

CURE

SOXL

Direxion Daily Semiconductor Bull 3X ETF · $18.0B$15,583

$10,000 five years ago, dividends reinvested · they hold 0.0% in common

CUREMeasureSOXL

+63.4%Year to dateJan 1 → Nov 4+58.8%

+99.0%1 yearTotal return+37.3%

+34.3%3 years · per year$10,000 became $24,209 · $46,695+67.1%

+10.2%5 years · per year$10,000 became $16,282 · $15,583+9.3%

0.94%Expense ratio$94 · $91 a year on $10k · lower is better0.91%

0.70%Trailing 12-mo yield$70 · $14 a year on $10k0.14%

−31.1%Worst dropSmaller is better−77.8%

48.7%VolatilityLower is calmer143.0%

CURESOXL Winner of the row, in its colourEach row: the bigger of the two fills its side

6–2CURE wins

End-of-day Nov 4, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

CURE vs SOXL: Top 5 Holdings

Today

CURE

9.4%in top 5

SOXL

in top 57.1%

CUREStockSOXL

3.5%LLYnot top 5

2.0%JNJnot top 5

not top 5AMD1.6%

1.6%ABBVnot top 5

not top 5NVDA1.5%

not top 5AVGO1.4%

not top 5MU1.4%

1.1%UNHnot top 5

1.1%MRKnot top 5

not top 5INTC1.1%

Held in common0.0%

End-of-day Nov 4, 2026 · share of each fund

CURE vs SOXL Returns, Every Period

DirexionCURE

+10.2%

5 years, per year

SOXLDirexion

+9.3%

5 years, per year

CURESOXLFaded: behind in that period

3–1CURE wins

End-of-day Nov 4, 2026 · dividends in · faded = behind in that period

CURE vs SOXL

YTD

DirexionCURE

+63.4%

SOXLDirexion

+58.8%

+63.4%Year to date+58.8%

−31.1%Worst drop · 1Y−77.8%

48.7%Volatility · 1Y143.0%

0.7%Yield0.1%

$200MAssets$18.0B

4–0CURE wins

End-of-day Nov 4, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: CURE, SOXL

Today

0.91%lowest, SOXL

FundExpense ratioFee$10k

SOXL0.91%$91

CURE0.94%$94

End-of-day Nov 4, 2026 · fee on $10,000 a year

Yields: CURE, SOXL

0.70%highest, CURE

FundTrailing yieldYield$10k

CURE0.70%$70

SOXL0.14%$14

End-of-day Nov 4, 2026 · trailing 12-month yield

Income After Fees on $10,000

−$24most kept, CURE

CURE$70 − $94 = −$24

SOXL$14 − $91 = −$77

KeptFee

End-of-day Nov 4, 2026 · yield in dollars minus the fee

Overlap: CURE, SOXL

Today

0.0%most shared, CURE and SOXL

CURESOXL

CURE—0.0%

SOXL0.0%—

End-of-day Nov 4, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

+99.0%CURE, at 48.7% volatility

CUREWorst drop−31.1%48.7% vol

SOXLWorst drop−77.8%143.0% vol

End-of-day Nov 4, 2026 · up and left is better

Paid More vs Made More

YTD

CURESOXL

+63.4%Year to date+58.8%

0.7%Yield0.1%

+99.0%Past year+37.3%

0.94%Fee0.91%

3–1CURE wins

End-of-day Nov 4, 2026

Popular Pairs Near These Two

SOXX vs SMH

YTD

iSharesSOXX

+49.8%

SMHVanEck

+40.0%

+49.8%Year to date+40.0%

0.33% · $33Fee · on $10k a year0.35% · $35

$44.3BAssets$65.8B

2–0SOXX wins

End-of-day Nov 4, 2026

SCHD vs VIG

YTD

SchwabSCHD

+35.3%

VIGVanguard

+16.4%

+35.3%Year to date+16.4%

2.9%Yield1.4%

$121BAssets$109B

2–0SCHD wins

End-of-day Nov 4, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+8.5%

JEPIJ.P. Morgan

+8.8%

+8.5%Year to date+8.8%

12.2%Yield7.8%

$41.8BAssets$46.0B

1–1level

End-of-day Nov 4, 2026